Author

Jia Lv

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Novel 2,4-Pyrimidinediamine Derivative as Potent EGFR Inhibitor for NSCLC Treatment

Aberrant activation of EGFR drives the progression of non-small-cell lung cancer (NSCLC). As one of the most prevalent driver genes in NSCLC, EGFR represents a critical therapeutic target for patients with NSCLC. In this study, we synthesized 2,4-pyrimidinediamine derivative ZX-3. Compared to its lead compound ceritini...

Shi-Qi Jia, Xiao-Lin Lv, Jia Lv et al. · Molecules · 0 citations